Literature DB >> 8224735

The evidence for the existence of cannabinoid receptors.

R Pertwee1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8224735     DOI： 10.1016/0306-3623(93)90154-p

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN： 0306-3623


× No keyword cloud information.
  12 in total

1.  Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.

Authors:  A S Bloom; W S Edgemond; J C Moldvan
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

Review 2.  The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.

Authors:  Federico Massa; Martin Storr; Beat Lutz
Journal:  J Mol Med (Berl)       Date:  2005-08-26       Impact factor: 4.599

3.  Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death.

Authors:  Jia Chen; Chun-Ting Lee; Stacie Errico; Xiaolin Deng; Jean L Cadet; William J Freed
Journal:  Brain Res Mol Brain Res       Date:  2005-04-04

4.  Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.

Authors:  C C Huang; S W Lo; K S Hsu
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

5.  Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization.

Authors:  W Jin; S Brown; J P Roche; C Hsieh; J P Celver; A Kovoor; C Chavkin; K Mackie
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  Identification of a high-affinity binding site involved in the transport of endocannabinoids.

Authors:  S A Moore; G G Nomikos; A K Dickason-Chesterfield; D A Schober; J M Schaus; B-P Ying; Y-C Xu; L Phebus; R M A Simmons; D Li; S Iyengar; C C Felder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-28       Impact factor: 11.205

7.  Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor.

Authors:  D E Garcia; S Brown; B Hille; K Mackie
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

8.  Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects.

Authors:  W J Martin; A G Hohmann; J M Walker
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

9.  Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.

Authors:  R G Pertwee; L A Stevenson; G Griffin
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice.

Authors:  Dianne J M Delsing; Frank P Leijten; Karin Arts; Hans van Eenennaam; Anja Garritsen; Marion J J Gijbels; Menno P J de Winther; Andrea van Elsas
Journal:  Open Cardiovasc Med J       Date:  2011-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.